missing translation for 'onlineSavingsMsg'
Läs mer

MP Biomedicals Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card

Produktkod. 30280603 Handla allt MP Biomedicals Produkter
Change view
Klicka för att se tillgängliga alternativ
:
SARS-CoV-2 and Ifnluence Duo
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Produktkod.
30280603 SARS-CoV-2 and Ifnluence Duo
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Denna artikel kan inte returneras. Se returpolicy
Produktkod. 30280603 Leverantör MP Biomedicals Leverantörsnummer 07AG6020FL

Vänligen för att beställa denna produkten. Behöver du ett Webbkonto? Registrera ditt konto idag!

Denna artikel kan inte returneras. Se returpolicy

SARS-CoV-2 Ag+Flu A/Flu B Rapid Test is a one-step in vitro test based on immunochromatography.

  • Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatographic lateral flow device that employs the principle of double antibody sandwich method.
  • Anti-SARS-CoV-2, anti-influenza A and anti-influenza B antibodies are immobilized on the nitrocellulose membrane respectively, as three individual test lines (CoV line, Flu A line and Flu B line) in the test window of the test device.
  • When the specimen is added, it migrates by capillary diffusion through the strip to re-hydrate the gold conjugate complexes.
  • If present at or above the limit of detection, viral antigens will react with the gold conjugate complexes to form particles, which will continue to migrate along the strip until the Test Zone (T) where they are captured by the immobilized anti-SARS-CoV-2 or anti-influenza A or anti-influenza B antibodies to form a visible red line, which indicates positive test results.
  • Absence of this colored band in the test window indicates a negative test result.
  • The gold conjugate complexes will continue to migrate alone until being captured by immobilized antibody in the Control Zone (C) to form a red line, which indicates the validity of the test.
  • CE marked
  • For professional use only
  • Accurate Result within 15 to 20 minutes
  • One-step procedure
  • No equipment needed
  • No cross-reaction
  • High sensitivity, specificity, and accuracy
  • This test is only to be used by professional medical staff, not for home testing. It cannot be used alone as the basis for the diagnosis and exclusion of cases.

Specifikationer

CE-märkning Self-declared
Clia komplexitet Not Applicable
Detekterbara analyter SARS-CoV-2, Influenza A and Influenza B Nucleoprotein Antigens
Detektionsmetod Immunochromatographic lateral flow
DoA-kalibratorer No
Formatera Test card
Provtyp Human nasal swabs, Human nasopharyngeal swabs, Human oropharyngeal swabs
Känslighet SARS-CoV-2: 1.3 x 102 TCID{50}/mL, Influenza A: 1.78 x 102 TCID{50}/mL, Influenza B: 1.17 x 103 TCID{50}/mL
Typ Rapid Test
Disponibel Single-use
För användning med (applikation) Rapid and qualitative determination of SARS-CoV-2, Influenza type A and type B viral antigen in nasal swabs, nasopharyngeal swabs or oropharyngeal swabs
Specificitet SARS-CoV-2: 99.16% (95% CI: 98.49% ~ 99.83%) Influenza A: 98.69% (95% CI: 97.42% ~ 99.97%) Influenza B: 99.37% (95% CI: 98.50% ~ 100%)
Form Ready-to-Use (RTU)
Visa mer Visa mindre
Produkttitel
Välj ett problem

Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.